Arimoclomol in Amyotropic Lateral Sclerosis

NCT03491462 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

245

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Arimoclomol
DRUG: Placebo

Sponsor

ZevraDenmark